Stratos Wealth Partners, Ltd. Geron Corp Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$0.98 - $1.85 $784 - $1,480	-800 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$1.76 - $6.38 $19,360 - $70,180	-11,000 Reduced 93.22%	800 $1,000
Q2 2018 Aug 13, 2018	BUY	$3.29 - $4.82 $36,190 - $53,020	11,000 Added 1375.0%	11,800 $40,000
Q1 2018 May 10, 2018	SELL	$1.81 - $5.98 $70,906 - $234,266	-39,175 Reduced 98.0%	800 $3,000
Q4 2017 Feb 09, 2018	BUY	$1.8 - $2.32 $71,955 - $92,742	39,975	39,975 $72,000

295

496M

799K

463K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $589M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.